Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Nov;85(10):1504–1509. doi: 10.1054/bjoc.2001.2097

Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes

C J Luscombe 1, M E French 1, S Liu 1, M F Saxby 1, P W Jones 2, A A Fryer 3, R C Strange 3
PMCID: PMC2363930  PMID: 11720436

Abstract

Exposure to ultraviolet radiation may reduce prostate cancer risk, suggesting that polymorphism in genes that mediate host pigmentation will be associated with susceptibility to this cancer. We studied 210 prostate cancer cases and 155 controls to determine whether vitamin D receptor (VDR, Taql and Fokl variants), tyrosinase (TYR, codon 192 variant) and melanocortin-1 receptor (MC1R, Arg151Cys, Arg160Trp, Val92Met, Asp294His and Asp84Glu variants) genotypes are associated with risk. UV exposure was determined using a questionnaire. MC1R Arg160/Arg160 homozygotes were at increased risk (P = 0.027, odds ratio = 1.94) while TYR A2/A2 homozygotes were at reduced risk of prostate cancer (P = 0.033, odds ratio = 0.48). These associations remained significant after correction for UV-exposure. Stratification of cases and controls by quartiles of exposure, showed that the protective effect of TYR A1A2 (P = 0.006, odds ratio 0.075) and A2A2 (P = 0.003, odds ratio 0.055) was particularly strong in subjects who had received the greatest exposure. Our data show for the first time, that allelism in genes linked with skin pigment synthesis is associated with prostate cancer risk possibly because it mediates the protective effects of UV. Importantly, susceptibility is associated with an interaction between host predisposition and exposure. © 2001 Cancer Research Campaign  http://www.bjcancer.com

Keywords: prostate cancer, susceptibility, polymorphism, ultraviolet radiation

Full Text

The Full Text of this article is available as a PDF (71.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Malek Z., Suzuki I., Tada A., Im S., Akcali C. The melanocortin-1 receptor and human pigmentation. Ann N Y Acad Sci. 1999 Oct 20;885:117–133. doi: 10.1111/j.1749-6632.1999.tb08669.x. [DOI] [PubMed] [Google Scholar]
  2. Box N. F., Wyeth J. R., O'Gorman L. E., Martin N. G., Sturm R. A. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet. 1997 Oct;6(11):1891–1897. doi: 10.1093/hmg/6.11.1891. [DOI] [PubMed] [Google Scholar]
  3. Cuzick J. Interaction, subgroup analysis and sample size. IARC Sci Publ. 1999;(148):109–121. [PubMed] [Google Scholar]
  4. Ekman P., Pan Y., Li C., Dich J. Environmental and genetic factors: a possible link with prostate cancer. Br J Urol. 1997 Apr;79 (Suppl 2):35–41. doi: 10.1111/j.1464-410x.1997.tb16919.x. [DOI] [PubMed] [Google Scholar]
  5. Garland C. F., Garland F. C. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980 Sep;9(3):227–231. doi: 10.1093/ije/9.3.227. [DOI] [PubMed] [Google Scholar]
  6. Garland F. C., Garland C. F., Gorham E. D., Young J. F. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990 Nov;19(6):614–622. doi: 10.1016/0091-7435(90)90058-r. [DOI] [PubMed] [Google Scholar]
  7. Giebel L. B., Spritz R. A. RFLP for MboI in the human tyrosinase (TYR) gene detected by PCR. Nucleic Acids Res. 1990 May 25;18(10):3103–3103. doi: 10.1093/nar/18.10.3103-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hanchette C. L., Schwartz G. G. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer. 1992 Dec 15;70(12):2861–2869. doi: 10.1002/1097-0142(19921215)70:12<2861::aid-cncr2820701224>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  9. Harvey I., Frankel S., Marks R., Shalom D., Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study. Br J Cancer. 1996 Oct;74(8):1308–1312. doi: 10.1038/bjc.1996.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harvey I., Frankel S., Marks R., Shalom D., Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer. 1996 Oct;74(8):1302–1307. doi: 10.1038/bjc.1996.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Haussler M. R., Whitfield G. K., Haussler C. A., Hsieh J. C., Thompson P. D., Selznick S. H., Dominguez C. E., Jurutka P. W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998 Mar;13(3):325–349. doi: 10.1359/jbmr.1998.13.3.325. [DOI] [PubMed] [Google Scholar]
  12. Hutchinson P. E., Osborne J. E., Lear J. T., Smith A. G., Bowers P. W., Morris P. N., Jones P. W., York C., Strange R. C., Fryer A. A. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res. 2000 Feb;6(2):498–504. [PubMed] [Google Scholar]
  13. Ichii-Jones F., Lear J. T., Heagerty A. H., Smith A. G., Hutchinson P. E., Osborne J., Bowers B., Jones P. W., Davies E., Ollier W. E. Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol. 1998 Aug;111(2):218–221. doi: 10.1046/j.1523-1747.1998.00287.x. [DOI] [PubMed] [Google Scholar]
  14. Ingles S. A., Ross R. K., Yu M. C., Irvine R. A., La Pera G., Haile R. W., Coetzee G. A. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst. 1997 Jan 15;89(2):166–170. doi: 10.1093/jnci/89.2.166. [DOI] [PubMed] [Google Scholar]
  15. Kricker A., Armstrong B. K., English D. R. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control. 1994 Jul;5(4):367–392. doi: 10.1007/BF01804988. [DOI] [PubMed] [Google Scholar]
  16. Kripke M. L. Ultraviolet radiation and immunology: something new under the sun--presidential address. Cancer Res. 1994 Dec 1;54(23):6102–6105. [PubMed] [Google Scholar]
  17. Lecrenier N., Foury F., Goffeau A. Two-hybrid systematic screening of the yeast proteome. Bioessays. 1998 Jan;20(1):1–5. doi: 10.1002/(SICI)1521-1878(199801)20:1<1::AID-BIES2>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  18. Lichtenstein P., Holm N. V., Verkasalo P. K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000 Jul 13;343(2):78–85. doi: 10.1056/NEJM200007133430201. [DOI] [PubMed] [Google Scholar]
  19. Luscombe C. J., Fryer A. A., French M. E., Liu S., Saxby M. F., Jones P. W., Strange R. C. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet. 2001 Aug 25;358(9282):641–642. doi: 10.1016/S0140-6736(01)05788-9. [DOI] [PubMed] [Google Scholar]
  20. Marks R. Sunlight and health. Use of sunscreens does not risk vitamin D deficiency. BMJ. 1999 Oct 16;319(7216):1066–1068. [PMC free article] [PubMed] [Google Scholar]
  21. McCarty M. F. Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypotheses. 2000 Mar;54(3):475–482. doi: 10.1054/mehy.1999.0880. [DOI] [PubMed] [Google Scholar]
  22. Oetting W. S., King R. A. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat. 1999;13(2):99–115. doi: 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  23. Palmer J. S., Duffy D. L., Box N. F., Aitken J. F., O'Gorman L. E., Green A. C., Hayward N. K., Martin N. G., Sturm R. A. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet. 2000 Jan;66(1):176–186. doi: 10.1086/302711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Perneger T. V. What's wrong with Bonferroni adjustments. BMJ. 1998 Apr 18;316(7139):1236–1238. doi: 10.1136/bmj.316.7139.1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ramsay H. M., Fryer A. A., Reece S., Smith A. G., Harden P. N. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis. 2000 Jul;36(1):167–176. doi: 10.1053/ajkd.2000.8290. [DOI] [PubMed] [Google Scholar]
  26. Rees J. L., Healy E. Melanocortin receptors, red hair, and skin cancer. J Investig Dermatol Symp Proc. 1997 Aug;2(1):94–98. doi: 10.1038/jidsymp.1997.18. [DOI] [PubMed] [Google Scholar]
  27. Studzinski G. P., Moore D. C. Sunlight--can it prevent as well as cause cancer? Cancer Res. 1995 Sep 15;55(18):4014–4022. [PubMed] [Google Scholar]
  28. Taylor J. A., Hirvonen A., Watson M., Pittman G., Mohler J. L., Bell D. A. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996 Sep 15;56(18):4108–4110. [PubMed] [Google Scholar]
  29. Valverde P., Healy E., Jackson I., Rees J. L., Thody A. J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet. 1995 Nov;11(3):328–330. doi: 10.1038/ng1195-328. [DOI] [PubMed] [Google Scholar]
  30. Xue W., Irvine R. A., Yu M. C., Ross R. K., Coetzee G. A., Ingles S. A. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res. 2000 Feb 15;60(4):839–841. [PubMed] [Google Scholar]
  31. Young J. M., Muscatello D. J., Ward J. E. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. BJU Int. 2000 Jun;85(9):1037–1048. doi: 10.1046/j.1464-410x.2000.00659.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES